About Antares Therapeutics
Antares Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2025 in Delaware. It has reported $70,000,000 raised in two offerings on Form D since March 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 1, 2025 | May 15, 2025 | $30,000,000of $136.6M target | 35 | $857K | EquityRule 506(b) | Form D ↗ |
| Mar 5, 2025 | Mar 12, 2025 | $40,000,000fully sold | 3 | $13.3M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $70,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Antares Therapeutics's Form D filed May 15, 2025.
AF
MP
Menelas Pangalos
Director
JA
KF
JF
AF
Adam Friedman
Executive officer and director
Also a chief executive officer and director at Scorpion Therapeutics.
BP
SC